18F-FDG PET/CT Prognostic Parameters in Patients with Head and Neck Cancer.

Fluorodeoxyglucose Positron Emission Tomography as Predictive Factor for the Outcome of Head and Neck Cancer Patients

F 18 FDG PET/CT in Evaluation of Loco-regional and Distant Recurrent Cervical Carcinoma.

Patterns and Prevalence of Post-Radiation Changes in Head & Neck Cancer Detected by 18F-FDG PET/CT

Value of Initial 18F-FDG PET/CT in Change of Management of Patients with Differentiated Thyroid Cancer as Compared to Post Ablative Whole Body Iodine Scan.

The Impact of 18F-FDG-PET/CT Versus Conventional Imaging Modalities in Pediatric Nasopharyngeal Carcinoma.

18F FDG PET/CT EVALUATION OF PATIENTS WITH CERVICAL CARCINOMA IAGARU, A.(1), EL-MAGHRABY, T. (2), QUON, A. (1), GAMBHIR, S.S. (1) and MCDOUGALL, I.R. (1) (1) Nuclear Medicine Division, Stanford University Hospital, California, USA and (2) Nuclear Medicine Unit, Cairo University Hospitals, Cairo, Egypt,

Role of PET/CT in the management of head and neck cancer

Value of F-18 FDG PET/CT Compared to Conventional Imaging in changing management of Patients with Differentiated Thyroid Cancer before radioactive iodine ablation.

18FDG-PET/CT versus Contrast Enhanced CT in Detection of Loco-Regional Breast Cancer Recurrence.